BDBM311095 N-ethyl-N-(2-(4-(2- hydroxypropan-2-yl)- 5-methyl-2H-1,2,3- triazol-2-yl)ethyl)-2- propylbenzamide::US10155750, Example 32

SMILES CCCc1ccccc1C(=O)N(CC)CCn1nc(C)c(n1)C(C)(C)O

InChI Key InChIKey=MXDSXUGCTPNELS-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 311095   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM311095(US10155750, Example 32 | N-ethyl-N-(2-(4-(2- hydro...)
Affinity DataIC50: 32nMAssay Description:The cells are seeded at 20,000 cells/well into Becton-Dickinson black 384-well clear bottom sterile plates coated with poly-D-lysine. All reagents we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM311095(US10155750, Example 32 | N-ethyl-N-(2-(4-(2- hydro...)
Affinity DataIC50: 2.21E+3nMAssay Description:The cells are seeded at 20,000 cells/well into Becton-Dickinson black 384-well clear bottom sterile plates coated with poly-D-lysine. All reagents we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent